News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
BioImagene, Inc. Announces Appointment of ForteBio CEO - Dr. Joseph D. Keegan to Its Board of Directors
January 15, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CUPERTINO, Calif.--(BUSINESS WIRE)--BioImagene, a leading provider of innovative imaging software and systems for cancer diagnosis and research is pleased to announce Dr. Joseph Keegan’s appointment as a director to the company’s board.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Licensing
AbbVie grooves with DISCO’s solid tumor tech in up to $2.5B licensing deal
November 19, 2026
·
1 min read
·
Annalee Armstrong
Layoffs
9 biotechs will cut at least half their California workforces
November 19, 2026
·
6 min read
·
Angela Gabriel
Drug Development
Merck scraps centerpiece of $2.7B ArQule buy after late-stage safety concerns
November 18, 2026
·
2 min read
·
Gabrielle Masson
Government
Government actions are hitting smaller biotechs the hardest: Report
November 18, 2026
·
2 min read
·
Nick Paul Taylor